ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
2,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
3,2,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
4,1,Injection site cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
4,2,Necrosis,Necrosis NEC,Tissue disorders NEC,Genrl,N
5,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
5,2,Arthritis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
6,1,Coma,Coma states,Neurological disorders NEC,Nerv,N
6,2,Miosis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
6,3,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
7,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
8,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
8,2,Hydrocephalus,Hydrocephalic conditions,Increased intracranial pressure and hydrocephalus,Nerv,N
8,3,Idiopathic pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
8,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
9,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
9,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
9,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
10,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
10,2,Conversion disorder,Somatic symptom disorders,Somatic symptom and related disorders,Psych,N
10,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
11,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
11,2,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
11,3,Spleen disorder,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
11,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
12,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
13,1,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,Y
14,1,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
15,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
15,2,Dystonia,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
16,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
16,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
16,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
17,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
18,1,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,Y
19,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
20,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
21,1,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
22,1,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
23,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
24,1,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
24,2,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
24,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
25,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
26,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
26,2,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
27,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
28,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
28,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
29,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
29,2,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
29,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
29,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
29,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
29,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
29,7,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
30,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
30,2,Dystonia,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
30,3,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
31,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
31,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
31,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
32,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
33,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
33,2,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
34,1,Extrapyramidal disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
34,2,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
35,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
36,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
36,2,Choreoathetosis,Choreiform movements,Movement disorders (incl parkinsonism),Nerv,N
36,3,Dystonia,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
37,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
38,1,Headache,Headaches NEC,Headaches,Nerv,N
39,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
40,1,Dermatitis exfoliative,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
41,1,Dystonia,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
42,1,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
42,2,Speech disorder developmental,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
43,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
43,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
44,1,Tardive dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
45,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
45,2,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,Y
45,3,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
46,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
46,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
46,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
46,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
47,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
47,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
47,3,Functional gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
47,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
47,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
47,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
47,7,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
48,1,Cardiovascular disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
49,1,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
50,1,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
51,1,Coma,Coma states,Neurological disorders NEC,Nerv,N
51,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
51,3,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
52,1,Coma,Coma states,Neurological disorders NEC,Nerv,N
52,2,Heart rate decreased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
53,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
53,2,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
54,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
54,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
55,1,Bone disorder,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
55,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
55,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
55,4,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
55,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
55,6,Spinal compression fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
55,7,Spinal fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
55,8,Spinal fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
56,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
56,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
56,3,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
56,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
56,5,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
56,6,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
57,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
58,1,Euphoric mood,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
58,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
58,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
58,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
59,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
59,2,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
59,3,Symptom recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
60,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
60,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
60,3,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
60,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
60,5,Symptom recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
61,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
61,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
62,1,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
63,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
63,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
63,3,Product supply issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
63,4,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
64,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
64,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
64,3,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
64,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
64,5,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
64,6,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
64,7,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
64,8,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
64,9,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
64,10,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
64,11,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
65,1,Breast mass,Breast disorders NEC,Breast disorders,Repro,N
65,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
65,3,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
65,4,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
65,5,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
65,6,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
66,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
66,2,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
66,3,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
66,4,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
66,5,Near death experience,Perception disturbances NEC,Disturbances in thinking and perception,Psych,N
66,6,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
66,7,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
66,8,Therapeutic response unexpected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
66,9,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
66,10,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
